W.L.Gore & Associates clinical trial pipeline

4 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 1 with a minor change only.

1. Notable

   InnAVasc Arteriovenous Graft for Hemodialysis Access · End-Stage…InnAVasc Arteriovenous Graft for Hemodialysis Access · End-Stage Renal Disease

   Primary completion pushed from Dec 1, 2027 to Mar 1, 2030

   Also in this update: Study completion pushed from Jul 1, 2029 to Sep 1, 2031

   W.L.Gore & Associates·Not applicable· NCT04671771· Registry history of NCT04671771 on ClinicalTrials.gov (opens the registry)

   Updated Oct 8, 2026

2. Notable

   VIATIPS · VIATORR® TIPS Study Evaluating 6-10mm Diameters…VIATIPS · VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)

   Recruitment opened

   W.L.Gore & Associates·Not specified· NCT07390344· Registry history of NCT07390344 on ClinicalTrials.gov (opens the registry)

   Updated Sep 18, 2026

3. Notable

   MBA Early Feasibility Study

   Recruitment opened

   Also in this update: Primary completion moved earlier from Nov 2029 to Aug 2028; Study completion moved earlier from Nov 2034 to Aug 2033

   W.L.Gore & Associates·Not applicable· NCT07564375· Registry history of NCT07564375 on ClinicalTrials.gov (opens the registry)

   Updated Sep 16, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.